| Apr 13 2020 |
Celgene v. Sun Pharma Global: Satisfying Subject Matter Jurisdiction Under § 271(e)(2) |
Mintz |
| Apr 13 2020 |
Washington State Announces PFASs in Food Packaging AA Webinar |
Keller and Heckman LLP |
| Apr 12 2020 |
Agriculture Provisions in the CARES Act |
Greenberg Traurig, LLP |
| Apr 12 2020 |
New Jersey Division of Alcoholic Beverage Control Adapts to COVID-19 Realities |
Norris McLaughlin P.A. |
| Apr 12 2020 |
HHS Distributes $30B to FFS Medicare Providers |
McDermott Will & Schulte LLP |
| Apr 11 2020 |
FEMA Rules to Restrict PPE Exports for US COVID-19 Response |
Squire Patton Boggs (US) LLP |
| Apr 10 2020 |
COVID-19: DEA and SAMHSA Guidance for Treating Opioid Use Disorders via Telehealth |
Foley & Lardner LLP |
| Apr 10 2020 |
EUON Announces That Female Fertility Data Are Lacking for Nanomaterials |
Bergeson & Campbell, P.C. |
| Apr 10 2020 |
Natural Cosmetics: Products Without a Clear Definition |
Faegre Drinker |
| Apr 10 2020 |
FDA Zantac Recall: Too Little, Too Late |
Stark & Stark |
| Apr 10 2020 |
FDA Issues Warning Letter for Fraudulent COVID-19 Treatment Product |
Keller and Heckman LLP |
| Apr 10 2020 |
Considerations for Companies Interested in Manufacturing Hand Sanitizer to Fight Against COVID-19 |
Squire Patton Boggs (US) LLP |
| Apr 9 2020 |
Massachusetts Issues COVID-19 Orders and Guidance for Providers |
Robinson & Cole LLP |
| Apr 9 2020 |
How Can We Get Back to Work? The Importance of Response Planning to a Confirmed COVID-19 Case |
Womble Bond Dickinson (US) LLP |
| Apr 9 2020 |
EPA Will Host April 16 Call on TSCA Fees for EPA-Initiated Risk Evaluations |
Bergeson & Campbell, P.C. |
| Apr 9 2020 |
Health Canada Announces New Master File Fees |
Keller and Heckman LLP |
| Apr 9 2020 |
U.S. District Judge Dismisses Sugar Claim Against Kombucha Drink Maker But Allows Alcohol Content Claim to Proceed |
Keller and Heckman LLP |
| Apr 9 2020 |
COVID-19 Unsympathetic to TSCA Compliance |
Keller and Heckman LLP |
| Apr 9 2020 |
“Method of Preparation” Claims Found Patent-Eligible Under §101 |
McDermott Will & Schulte LLP |
| Apr 9 2020 |
United States Intervenes and Settles Qui Tam False Claims Act Case Against Compound Pharmacies for $426,000 |
Kohn, Kohn & Colapinto |
| Apr 9 2020 |
Update: Key FDA Actions for COVID-19 Devices and Therapies |
Sheppard, Mullin, Richter & Hampton LLP |
| Apr 8 2020 |
National Academies Publish Quadrennial Review of NNI |
Bergeson & Campbell, P.C. |
| Apr 8 2020 |
DOT Issues COVID-19 Enforcement Discretion for Cylinder Requalification Requirements |
Keller and Heckman LLP |
| Apr 8 2020 |
La Croix Loses Rule 11 Battle but Wins War, as Plaintiff Retracts Lawsuit Allegations |
Proskauer Rose LLP |
| Apr 8 2020 |
COVID-19 Update: When Computers Invent: How the Use of Artificial Intelligence to Treat COVID-19 Highlights Novel Inventorship Issues |
Cadwalader, Wickersham & Taft LLP |
| Apr 8 2020 |
Making Sense of FDA’s Recent Guidances on Personal Protective Equipment (PPE) |
Womble Bond Dickinson (US) LLP |
| Apr 8 2020 |
USDA Decides to Initiate COOL Rulemaking to Clear Consumer Confusion |
Keller and Heckman LLP |
| Apr 8 2020 |
If Successful, Teva Suit Could Decrease Generic Competition |
ArentFox Schiff LLP |
| Apr 7 2020 |
Personalized Medicine Coalition Releases Spring 2020 Newsletter Amid COVID-19 |
Foley & Lardner LLP |
| Apr 7 2020 |
Nota Bene Episode 73: “Quarantine and Chill”: Will COVID-19 Impact the Cannabis Industry? with Whitney Hodges |
Sheppard, Mullin, Richter & Hampton LLP |
| Apr 7 2020 |
Supreme Court Will Address Personal Jurisdiction After States Courts Interpret BMS Decision |
ArentFox Schiff LLP |
| Apr 7 2020 |
FDA Temporarily Relaxes Policies Relating to Eggs Produced for and Sold in the Retail Market |
Keller and Heckman LLP |
| Apr 6 2020 |
CARES Act Prompts Changes to Employer-Sponsored Health Plans |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Apr 6 2020 |
U.S. Department of Justice Issues First COVID-19-Related Business Review Letter to Medical Supplies Distributors |
Mintz |
| Apr 6 2020 |
CMS “Hospitals Without Walls” Waiver: Looking To ASCs to Provide Relief |
Sheppard, Mullin, Richter & Hampton LLP |
